SNYR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Synergy CHC Corp (SNYR) is not a good buy for a beginner, long-term investor at this time. Despite a Buy rating from an analyst and a positive pre-market price change, the company's financial performance is significantly deteriorating, technical indicators are bearish, and there are no strong positive catalysts or trading signals to support an immediate investment.
The stock is in a bearish trend with MACD below 0 and negatively expanding, RSI indicating oversold conditions at 10.883, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). Key support and resistance levels suggest a potential downside risk with the stock trading below the pivot level of 0.962.
The stock has a Buy rating from Ascendiant analyst Edward Woo with a $5 price target, citing large market opportunities for the company's brain health supplement FOCUSfactor. Pre-market price is up 2.80%.
Gross margin also dropped by -9.92% YoY. Technical indicators are bearish, and there is no recent news or significant trading activity from hedge funds, insiders, or Congress.
In Q4 2025, the company reported a revenue decline to $8,965,167 (-12.72% YoY), a net income loss of -$14,816,035 (-14121.44% YoY), and an EPS drop to -1.31 (-13200.00% YoY). Gross margin also decreased to 56.73 (-9.92% YoY).
Ascendiant analyst Edward Woo initiated coverage with a Buy rating and a $5 price target, citing large market opportunities for the company's brain health supplement FOCUSfactor.
